, * Publications that have not been peer-reviewed and are available on pre-publication servers
, WHO. WHO Coronavirus Disease (COVID-19) Dashboard, 2020.
SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, vol.181, pp.271-280, 2020. ,
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells, Proc. Natl Acad. Sci. USA, vol.117, pp.7001-7003, 2020. ,
Severe Covid-19, N. Engl. J. Med, 2020. ,
A dynamic immune response shapes COVID-19 progression, Cell Host Microbe, vol.27, pp.879-882, 2020. ,
COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS, Med. J. Aust, vol.213, pp.54-56, 2020. ,
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy, Lancet Resp. Med, vol.8, pp.807-815, 2020. ,
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int. J. Antimicrob. Agents, p.105949, 2020. ,
URL : https://hal.archives-ouvertes.fr/hal-02525126
Dexamethasone in Hospitalized Patients with Covid-19 -Preliminary Report, N. Engl. J. Med, 2020. ,
A novel coronavirus from patients with pneumonia in China, N. Engl. J. Med, vol.382, pp.727-733, 2019. ,
Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study, Lancet Microbe, vol.1, pp.14-23, 2020. ,
A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, vol.579, pp.270-273, 2020. ,
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV, Nat. Commun, vol.11, p.1620, 2020. ,
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa, Int. J. Oral Sci, vol.12, 2020. ,
Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions, Proc. Natl Acad. Sci. USA, vol.117, pp.13967-13974, 2020. ,
The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application, Ann. Intern. Med, vol.172, pp.577-582, 2020. ,
Clinical characteristics of coronavirus disease 2019 in China, N. Engl. J. Med, vol.382, pp.1708-1720, 2020. ,
Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, JAMA Intern. Med, vol.180, pp.934-943, 2020. ,
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study, BMJ, vol.368, p.1091, 2020. ,
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study, Eur. Respiratory J, vol.55, 2020. ,
OpenSAFELY: factors associated with COVID-19 death in 17 million patients, Nature ,
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes, Nat. Med, vol.26, pp.681-687, 2020. ,
Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Lancet Respir. Med, vol.8, pp.420-422, 2020. ,
The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities, Cardiovasc. Pathol, vol.48, pp.107233-107233, 2020. ,
Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19, N. Engl. J. Med, vol.383, pp.120-128, 2020. ,
IL-17 response mediates acute lung injury induced by the 2009 pandemic influenza A (H1N1) virus, Cell Res, vol.22, pp.528-538, 2012. ,
MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile, Cytokine, vol.104, pp.8-13, 2018. ,
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study, Signal Transduct. Tar. Ther, vol.5, p.33, 2020. ,
Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19), Front. Immunol, vol.11, p.827, 2020. ,
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients, Science, p.6027, 2020. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02900830
Dysregulation of immune response in patients with COVID-19 in Wuhan, China, Clin. Infect. Dis, vol.71, pp.762-768, 2020. ,
COVID-19: a case for inhibiting IL-17?, Nat. Rev. Immunol, vol.20, pp.345-346, 2020. ,
Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice, J. Virol, vol.78, pp.3572-3577, 2004. ,
Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice, J. Immunol, vol.173, pp.4030-4039, 2004. ,
Resolution of primary severe acute respiratory syndromeassociated coronavirus infection requires Stat1, J. Virol, vol.78, pp.11416-11421, 2004. ,
SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism, PLOS Pathog, vol.6, p.1000849, 2010. ,
Animal models for SARS and MERS coronaviruses, Curr. Opin. Virol, vol.13, pp.123-129, 2015. ,
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature, vol.426, pp.450-454, 2003. ,
Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus, J. Virol, vol.81, pp.813-821, 2007. ,
Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2, J. Virol, vol.82, pp.7264-7275, 2008. ,
Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection, Comp. Med, vol.57, pp.450-459, 2007. ,
Coronaviruses: important emerging human pathogens, J. Virol, vol.88, pp.5209-5212, 2014. ,
Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease, J. Virol, vol.89, pp.3659-3670, 2015. ,
Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection, J. Virol, vol.88, pp.4953-4961, 2014. ,
Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East Respiratory syndrome coronavirus infection, J. Virol, vol.88, pp.5195-5199, 2014. ,
Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4, J. Virol, vol.88, pp.9220-9232, 2014. ,
A mouse model for MERS coronavirus-induced acute respiratory distress syndrome, Nat. Microbiol, vol.2, p.16226, 2016. ,
Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice, Proc. Natl Acad. Sci. USA, vol.114, pp.3119-3128, 2017. ,
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses, Nat. Microbiol, vol.5, pp.562-569, 2020. ,
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice, Nature, vol.583, pp.830-833, 2020. ,
Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2, Cell, vol.182, pp.50-58, 2020. ,
SARS-like WIV1-CoV poised for human emergence, Proc. Natl Acad. Sci. USA, vol.113, pp.3048-3053, 2016. ,
Evaluation of K18-hACE2 Mice as a Model of SARS-CoV-2 Infection, Am. J. Tropical Med. Hygiene, ajtmh, pp.20-0762, 2020. ,
SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory function, 2020. ,
Lethality of SARS-CoV-2 infection in K18 human angiotensin converting enzyme 2 transgenic mice, vol.18, p.210179, 2020. ,
Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease, 2020. ,
K18-hACE2 mice develop dose-dependent disease, 2020. ,
Rapid generation of a mouse model for Middle East respiratory syndrome, Proc. Natl Acad. Sci. USA, vol.111, pp.4970-4975, 2014. ,
A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies, Cell, vol.182, pp.744-753, 2020. ,
A mouse model of SARS-CoV-2 infection and pathogenesis, Cell Host Microbe, vol.28, pp.124-133, 2020. ,
, Animal and translational models of SARS-CoV-2 infection and COVID-19
,
A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice, PLoS Pathog, vol.3, p.5, 2007. ,
A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo, Virology, vol.395, pp.210-222, 2009. ,
Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein, J. Virol, vol.87, pp.6551-6559, 2013. ,
Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease, Virology, vol.399, pp.120-128, 2010. ,
Rapid adaptation of SARS-CoV-2 in BALB/c mice: Novel mouse model for vaccine efficacy, 2020. ,
A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures, 2020. ,
Obesity is associated with increased risk for mortality among hospitalized patients with COVID-19, Obesity ,
Diabetes increases the mortality of patients with COVID-19: a meta-analysis, Acta Diabetol ,
& COVID Human Genetic Effort. A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection, Cell, vol.181, pp.1194-1199, 2020. ,
The genome architecture of the collaborative cross mouse genetic reference population, Genetics, vol.190, pp.389-401, 2012. ,
Mouse genomic variation and its effect on phenotypes and gene regulation, Nature, vol.477, pp.289-294, 2011. ,
The collaborative cross: a systems genetics resource for studying host-pathogen interactions, Cell Host Microbe, vol.25, pp.484-498, 2019. ,
Genome wide identification of SARS-CoV susceptibility loci using the collaborative cross, PLOS Genet, vol.11, p.1005504, 2015. ,
Allelic variation in the toll-like receptor adaptor protein Ticam2 contributes to SARS-coronavirus pathogenesis in mice, Bethesda), vol.3, pp.1653-1663, 2017. ,
Covid-19: risk factors for severe disease and death, BMJ, vol.368, p.1198, 2020. ,
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis, Int. J. Infect. Dis, vol.94, pp.91-95, 2020. ,
Cardiovascular disease, drug therapy, and mortality in Covid-19, N. Engl. J. Med, vol.382, p.102, 2020. ,
New-Onset Diabetes in Covid-19, N. Engl. J. Med, 2020. ,
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study, Lancet Glob. Health, vol.8, pp.1003-1017, 2020. ,
Targeting PI3K-p110alpha suppresses influenza virus infection in chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med, vol.191, pp.1012-1023, 2015. ,
MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD, JCI Insight, vol.2, p.90443, 2017. ,
Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis, PLoS ONE, vol.15, p.233147, 2020. ,
Cigarette smoke exposure and inflammatory signaling increase the expression of the SARS-CoV-2 receptor ACE2 in the respiratory tract, Dev. Cell, vol.53, pp.514-529, 2020. ,
A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis, J. Allergy Clin. Immunol, vol.131, pp.752-762, 2013. ,
Animal models of COPD: what do they tell us?, Respirology, vol.22, pp.21-32, 2017. ,
Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases, JCI Insight, vol.1, p.86380, 2016. ,
Importance of mast cell Prss31/transmembrane tryptase/ tryptase-? in lung function and experimental chronic obstructive pulmonary disease and colitis, J. Biol. Chem, vol.289, pp.18214-18227, 2014. ,
Antagonism of miR-328 increases the antimicrobial function of macrophages and neutrophils and rapid clearance of non-typeable haemophilus influenzae (NTHi) from infected lung, PLOS Pathog, vol.11, p.1004549, 2015. ,
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan, J. Allergy Clin. Immunol, vol.146, pp.110-118, 2020. ,
Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019-COVID-NET, 14 States, Morbidity Mortal. Wkly. Rep. (MMWR), vol.69, pp.458-464, 2020. ,
Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma, Immunol. Rev, vol.278, pp.41-62, 2017. ,
MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase-mediated suppression of histone deacetylase 2, J. Allergy Clin. Immunol, vol.139, pp.519-532, 2017. ,
Role for NLRP3 Inflammasome-mediated, IL-1beta-Dependent Responses in Severe, Steroid-Resistant Asthma, Am. J. Respir. Crit. Care Med, vol.196, pp.283-297, 2017. ,
Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors, Thorax, vol.60, pp.401-409, 2005. ,
The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis, Antivir. Res, vol.143, pp.142-150, 2017. ,
Follow-up study on pulmonary function and lung radiographic changes in rehabilitating severe acute respiratory syndrome patients after discharge, Chest, vol.127, pp.2119-2124, 2005. ,
Long-term bone and lung consequences associated with hospitalacquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study, Bone Res, vol.8, 2020. ,
SARS-CoV-2 induced transcriptional signatures in human lung epithelial cells that promote lung fibrosis, Respiratory Res, vol.21, p.182, 2020. ,
Fibulin-1c regulates transforming growth factor-? activation in pulmonary tissue fibrosis, JCI Insight, vol.5, p.124529, 2019. ,
Small mammalian animal models of heart disease, Am. J. Cardiovasc Dis, vol.6, pp.70-80, 2016. ,
Animal models of obesity and diabetes mellitus, Nat. Rev. Endocrinol, vol.14, pp.140-162, 2018. ,
Dietinduced type II diabetes in C57BL/6J mice, Diabetes, vol.37, pp.1163-1167, 1988. ,
The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes, Diabetes, vol.53, pp.215-219, 2004. ,
The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2, Cardiovasc. Res, vol.116, pp.1097-1100, 2020. ,
SARS-CoV-2 and diabetes: New challenges for the disease, Diabetes Res Clin. Pr, vol.164, p.108228, 2020. ,
Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse, Int. J. Mol. Sci, vol.18, p.563, 2017. ,
Influenza virus and glycemic variability in diabetes: a killer combination?, Front. Microbiol, vol.8, p.861, 2017. ,
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study, BMJ, vol.369, p.1966, 2020. ,
Why does COVID-19 disproportionately affect older people?, Aging, vol.12, pp.9959-9981, 2020. ,
Expression of the SARS-CoV-2 entry proteins, ACE2 and TMPRSS2, in cells of the olfactory epithelium: identification of cell types and trends with age, ACS Chem. Neurosci, vol.11, pp.1555-1562, 2020. ,
Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters, J. Virol, vol.79, pp.503-511, 2005. ,
Decrease in ACE2 mRNA expression in aged mouse lung, 2020. ,
Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants, PLoS Med, vol.3, p.525, 2006. ,
Ferret models of viral pathogenesis, Virology, vol.479, pp.259-270, 2015. ,
Pathology of experimental SARS coronavirus infection in cats and ferrets, Vet. Pathol, vol.45, pp.551-562, 2008. ,
The SARS-CoV ferret model in an infection-challenge study, Virology, vol.374, pp.151-163, 2008. ,
Virology: SARS virus infection of cats and ferrets, Nature, vol.425, p.915, 2003. ,
Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus, J. Virol, vol.94, pp.127-00120, 2020. ,
Animal and translational models of SARS-CoV-2 infection and COVID-19 ,
Infection and rapid transmission of SARS-CoV-2 in ferrets, Cell Host Microbe, vol.27, pp.704-709, 2020. ,
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2, Science, vol.368, pp.1016-1020, 2020. ,
Antiviral efficacies of FDA-approved drugs against SARS-CoV-2 infection in ferrets, vol.11, pp.1114-01120, 2020. ,
Imbalanced host response to SARS-CoV-2 drives development of COVID-19, Cell, vol.181, 2020. ,
Syrian hamster as an animal model for the study on infectious diseases, Front Immunol, vol.10, p.2329, 2019. ,
Production of genetically engineered golden Syrian hamsters by pronuclear injection of the CRISPR/Cas9 complex, J. Vis. Exp, vol.131, p.56263, 2018. ,
Characterization of an N-terminal non-core domain of RAG1 gene disrupted Syrian Hamster model generated by CRISPR Cas9, Viruses, vol.10, p.243, 2018. ,
STAT2 knockout Syrian hamsters support enhanced replication and pathogenicity of human adenovirus, revealing an important role of type I interferon response in viral control, PLoS Pathog, vol.11, p.1005084, 2015. ,
Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters, J. Infect. Dis, vol.193, pp.685-692, 2006. ,
An immunosuppressed Syrian golden hamster model for SARS-CoV infection, Virology, vol.380, pp.312-321, 2008. ,
Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility, Clin. Infect. Dis ,
Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection, Biochem. Biophys. Res. Commun, vol.526, pp.165-169, 2020. ,
Product development under the animal rule: Guidance for Industry, 2015. ,
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome, Lancet, vol.362, pp.263-270, 2003. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00167032
Aetiology: Koch's postulates fulfilled for SARS virus, Nature, vol.423, p.240, 2003. ,
Cynomolgus macaque as an animal model for severe acute respiratory syndrome, PLoS Med, vol.3, p.149, 2006. ,
Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys, Virology, vol.330, pp.8-15, 2004. ,
Macaque model for severe acute respiratory syndrome, J. Virol, vol.78, pp.11401-11404, 2004. ,
Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques, Nat. Med, vol.10, pp.290-293, 2004. ,
Exacerbated innate host response to SARS-CoV in aged nonhuman primates, PLoS Pathog, vol.6, p.1000756, 2010. ,
Comparative pathogenesis of three human and zoonotic SARS-CoV strains in cynomolgus macaques, PLoS ONE, vol.6, p.18558, 2011. ,
An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus, J. Pathol, vol.206, pp.251-259, 2005. ,
Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus, Am. J. Pathol, vol.167, pp.455-463, 2005. ,
Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques, Proc. Natl Acad. Sci. USA, vol.110, pp.16598-16603, 2013. ,
Pneumonia from human coronavirus in a macaque model, N. Engl. J. Med, vol.368, pp.1560-1562, 2013. ,
An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus, J. Infect. Dis, vol.209, pp.236-242, 2014. ,
Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets, Antivir. Res, vol.156, pp.64-71, 2018. ,
Infection with MERS-CoV causes lethal pneumonia in the common marmoset, PLoS Pathog, vol.10, p.1004250, 2014. ,
Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2, 2020. ,
Age-related rhesus macaque models of COVID-19, Anim. Model Exp. Med, vol.3, pp.93-97, 2020. ,
Comparison of SARS-CoV-2 infections among 3 species of nonhuman primates, 2020. ,
Comparative ACE2 variation and primate COVID-19 risk, 2020. ,
SARS-CoV-2 infection protects against rechallenge in rhesus macaques, Science, p.4776, 2020. ,
DNA vaccine protection against SARS-CoV-2 in rhesus macaques, Science, vol.369, pp.806-811, 2020. ,
ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques, Nature ,
COVID-19 vaccine (ChAdOx1 nCoV-19) trial in South African adults with and without HIV-infection, 2020. ,
Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic, Nat. Microbiol ,
SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study. Lancet Microbe, pp.30089-30095, 2020. ,
Global patterns in coronavirus diversity, Virus Evolution, vol.3, p.12, 2017. ,
Replication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis), Sci. Rep, vol.6, p.21878, 2016. ,
Bat coronaviruses and experimental infection of bats, the Philippines, Emerg. Infect. Dis, vol.16, pp.1217-1223, 2010. ,
Infection of bat and human intestinal organoids by SARS-CoV-2, Nat. Med, vol.26, pp.1077-1083, 2020. ,
Transcriptome Sequencing and Annotation for the Jamaican Fruit Bat (Artibeus jamaicensis), PLOS ONE, vol.7, p.48472, 2012. ,
Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). Department of Communicable Disease Surveillance and Response, pp.1-44, 2003. ,
Transmission of SARS-CoV-2 in Domestic Cats, N. Engl. J. Med, 2020. ,
First detection and genome sequencing of SARS-CoV-2 in an infected cat in France, Transbound Emerg. Dis ,
URL : https://hal.archives-ouvertes.fr/hal-02874788
First Reported Cases of SARS-CoV-2 Infection in Companion Animals, MMWR Morb. Mortal. Wkly Rep, vol.69, pp.710-713, 2020. ,
Leading Veterinary Diagnostic Company Sees No COVID-19 Cases in Pets, 2020. ,
SARS-CoV-2 neutralizing serum antibodies in cats: a serological investigation, 2020. ,
Infection of dogs with SARS-CoV-2. Nature, 2020. ,
Protecting poultry workers from exposure to avian influenza viruses, Public Health Rep, vol.123, pp.316-322, 2008. ,
Detecting human-tohuman transmission of avian influenza A (H5N1), Emerg. Infect. Dis, vol.13, pp.1348-1353, 2007. ,
Influenza virus propagation in embryonated chicken eggs, J. Vis. Exp, p.52421, 2015. ,
Susceptibility of pigs and chickens to SARS coronavirus, Emerg. Infect. Dis, vol.10, pp.179-184, 2004. ,
Domestic poultry and SARS coronavirus, southern China, Emerg. Infect. Dis, vol.10, pp.914-916, 2004. ,
Susceptibility of tree shrew to SARS-CoV-2 infection, 2020. ,
Surveillance and analysis of avian influenza viruses, Australia, Emerg. Infect. Dis, vol.16, pp.1896-1904, 2010. ,
Bronx Zoo Tigers and Lions Recovering from COVID-19, 2020. ,
SARS-CoV-2 infection in farmed minks, the Netherlands, Eurosurveillance, vol.25, p.2001005, 2020. ,
Seven more big cats test positive for coronavirus at Bronx Zoo, 2020. ,
Complete genome sequence of SARS-CoV-2 in a tiger from a U, S. zoological collection. Microbiol. Resour. Announcements, vol.9, pp.468-00420, 2020. ,
Bats are natural reservoirs of SARS-like coronaviruses, Science, vol.310, pp.676-679, 2005. ,
An extensive meta-metagenomic search identifies SARS-CoV-2-homologous sequences in pangolin lung viromes, vol.5, pp.160-00120, 2020. ,
Evidence of recombination in coronaviruses implicating pangolin origins of nCoV-2019, 2020. ,
, Animal and translational models of SARS-CoV-2 infection and COVID-19
,
Detection of SARS-coronavirus in both human and animals by RT-PCR, Wei Sheng Yan Jiu, vol.34, pp.412-415, 2005. ,
A novel bat coronavirus closely related to SARS-CoV-2 contains natural insertions at the S1/S2 cleavage site of the spike protein, Curr. Biol, vol.30, pp.2196-2203, 2020. ,
Coronavirus surveillance of wildlife in the Lao People's Democratic Republic detects viral RNA in rodents, Arch. Virol, vol.165, pp.1869-1875, 2020. ,
Viral Metagenomics revealed sendai virus and coronavirus infection of Malayan Pangolins (Manis javanica), Viruses, vol.11, p.979, 2019. ,
Growth and maintenance of Vero cell lines, Curr. Protoc. Microbiol. Appendix, vol.4, p.4, 2008. ,
ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia, J. Virol, vol.79, pp.14614-14621, 2005. ,
Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication, J. Virol, vol.79, pp.3846-3850, 2005. ,
Severe acute respiratory syndrome coronavirus 2 from patient with 2019 novel coronavirus disease, United States, Emerg. Infect. Dis, vol.26, pp.1266-1273, 2020. ,
Critical role of constitutive type I interferon response in bronchial epithelial cell to influenza infection, PLoS ONE, vol.7, p.32947, 2012. ,
House dust mite-promoted epithelial-to-mesenchymal transition in human bronchial epithelium, Am. J. Respir. Cell Mol. Biol, vol.42, pp.69-79, 2010. ,
Effect of long-term corticosteroid treatment on microRNA and gene-expression profiles in Chronic Obstructive Pulmonary Disease, Eur. Resp. J, p.1801202, 2019. ,
Respiratory syncytial virus co-opts host mitochondrial function to favour infectious virus production, Elife, vol.8, p.42448, 2019. ,
Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling, Elife, vol.6, p.20444, 2017. ,
SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery, 2020. ,
Rho-associated protein kinase inhibition enhances airway epithelial basal-cell proliferation and lentivirus transduction, Am. J. Resp. Cell Mol. Biol, vol.49, pp.341-347, 2013. ,
Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis, J. Intensive Care, vol.8, p.36, 2020. ,
Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a systemic review and meta-analysis, Int J. Infect. Dis, vol.96, pp.131-135, 2020. ,
Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro, J. Virol, vol.80, pp.2684-2693, 2006. ,
A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection, BMC Infect. Dis, vol.4, p.34, 2004. ,
Isolation, sequence, infectivity and replication kinetics of SARS-CoV-2. Emerg Infect Dis. eid2609, 2020. ,
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes, 2020. ,
SARS-CoV-2 infects T lymphocytes through its spike proteinmediated membrane fusion, Cell. Mol. Immunol, 2020. ,
Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways, J. Infect. Dis, vol.213, pp.904-914, 2015. ,
Pathogen reduction of SARS-CoV-2 virus in plasma and whole blood using riboflavin and UV light, PLOS ONE, vol.15, p.233947, 2020. ,
Cerebral organoids model human brain development and microcephaly, Nature, vol.501, pp.373-379, 2013. ,
Human blood vessel organoids as a model of diabetic vasculopathy, Nature, vol.565, pp.505-510, 2019. ,
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche, Nature, vol.459, pp.262-265, 2009. ,
Organoids of human airways to study infectivity and cytopathy of SARS-CoV-2, Lancet Resp. Med, pp.30238-30231, 2020. ,
In vitro generation of human pluripotent stem cell derived lung organoids, Elife, vol.4, p.5098, 2015. ,
Generation of lung organoids from human pluripotent stem cells in vitro, Nat. Protoc, vol.14, pp.518-540, 2019. ,
Organoids as a powerful model for respiratory diseases, Stem Cells Int, vol.2020, p.5847876, 2020. ,
Identification of candidate COVID-19 therapeutics using hPSCderived lung organoids, 2020. ,
Endothelial cell infection and endotheliitis in COVID-19, Lancet, vol.395, pp.1417-1418, 2020. ,
Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis, Crit. Care, vol.24, p.356, 2020. ,
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, vol.395, pp.497-506, 2020. ,
Neurologic Features in Severe SARS-CoV-2 Infection, N. Engl. J. Med, vol.382, pp.2268-2270, 2020. ,
SARS-CoV-2 productively infects human gut enterocytes, Science, vol.369, pp.50-54, 2020. ,
Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2, Cell, vol.181, pp.905-913, 2020. ,
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes, Sci. Immunol, vol.5, p.3582, 2020. ,
Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids, Protein Cell ,
Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 (APN01-COVID-19, 2020. ,
Critical role of type III interferon in controlling SARS-CoV-2 infection in human intestinal epithelial cells, Cell Rep, p.107863, 2020. ,
SARS-CoV-2 targets cortical neurons of 3D human brain organoids and shows neurodegeneration-like effects, 2020. ,
Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2, Altex. altex, 2020. ,
Pathophysiological regulation of lung function by the free fatty acid receptor FFA4, 2020. ,
Effect of perinatal secondhand tobacco smoke exposure on in vivo and intrinsic airway structure/ function in non-human primates, Toxicol. Appl. Pharm, vol.234, pp.339-344, 2009. ,
Neurally mediated airway constriction in human and other species: a comparative study using precision-cut lung slices (PCLS), PLOS ONE, vol.7, p.47344, 2012. ,
Critical role for iron accumulation in the pathogenesis of fibrotic lung disease, J. Pathol, vol.251, pp.49-62, 2020. ,
Influenza A virus infection and cigarette smoke impair bronchodilator responsiveness to ?-adrenoceptor agonists in mouse lung, Clin. Sci, vol.130, pp.829-837, 2016. ,
Airway remodelling and inflammation in asthma are dependent on the extracellular matrix protein fibulin-1c, J. Pathol, vol.243, pp.510-523, 2017. ,
Adenovirus type 7 induces interleukin-8 in a lung slice model and requires activation of Erk, J. Virol, vol.78, pp.4156-4164, 2004. ,
Replication characteristics of swine influenza viruses in precisioncut lung slices reflect the virulence properties of the viruses, Vet. Res, vol.44, pp.110-110, 2013. ,
Infection of murine precision cut lung slices (PCLS) with respiratory syncytial virus (RSV) and chlamydophila pneumoniae using the Krumdieck technique, Pathol. Res. Pr, vol.198, pp.747-753, 2002. ,
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses, Sci. Transl. Med, vol.9, p.3653, 2017. ,
Remdesivir for the Treatment of Covid-19 -Preliminary Report, N. Engl. J. Med, 2020. ,
Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells, Cell, vol.182, pp.73-84, 2020. ,
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model, Science, p.7520, 2020. ,
Dose translation from animal to human studies revisited, Faseb j, vol.22, pp.659-661, 2008. ,
Single-dose replicating RNA vaccine induces neutralizing antibodies against SARS-CoV-2 in nonhuman primates, 2020. ,
Modified vaccinia Ankara based SARS-CoV-2 vaccine expressing full-length spike induces strong neutralizing antibody response, 2020. ,
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 elicits immunogenicity in baboons and protection in mice, 2020. ,
A single dose of recombinant VSV-?G-spike vaccine provides protection against SARS-CoV-2 challenge, 2020. ,
Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV, Emerg. Microbes Infect, vol.7, p.77, 2018. ,
Early evidence of pronounced brain involvement in fatal COVID-19 outcomes, Lancet, vol.395, p.109, 2020. ,
, Animal and translational models of SARS-CoV-2 infection and COVID-19
,